Dennis O’Neill is the President at Biomedican, a biotech start-up company which developed a unique patented method of producing non-GMO rare cannabinoids like CBG, CBGA and THCV, THCVA.
Topics Discussed:
- Biomedican’s unique patented method of producing non-GMO rare cannabinoids
- Types of cannabinoid synthesis
- Non-GMO organic cannabis vs. chemically synthesized compounds
